Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta

J. R. Sheu, M. H. Yen, W. C. Hung, Y. M. Lee, Ching-Hua Su, T. F. Huang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Triflavin, a 7.5-kD cysteine-rich polypeptide purified from Trimeresurus favoviridis snake venom, belongs to a family of Arg-Gly-Asp-(RGD)-containing peptides, termed disintegrins. In this study, aggregating human platelets dose-dependently induced vasoconstriction in de-endothelialized isolated rat thoracic aortas. At 5 x 107 cells per milliliter, platelets induced a peak tension averaging 65±7.2% of the tension induced by phenylephrine (10 μmol/L). The relative effectiveness of RGD-containing peptides (including venom peptides triflavin and trigramin, small RGD synthetic peptides Gly- Arg-Gly-Asp-Ser [GRGDS], Gly-Arg-Gly-Asp-Phe [GRGDF], and Gly-Arg-Gly-Asp- Ser-Pro-Lys [GRGDSPK]) was examined by testing the inhibitory effect on aggregating platelet-induced vasoconstriction in de-endothelialized aorta. Triflavin (1 mmol/L) significantly inhibited the platelet-induced vasoconstriction, whereas neither trigramin (10 μmol/L) nor small RGD peptides (2 mmol/L) (ie, GRGDS, GRGDF, and GRGDSPK) showed any significant effect. The release of serotonin and the formation of thromboxane A2 from aggregating platelets were both significantly inhibited by triflavin (2 μmol/L), whereas trigramin and small RGD-containing peptides showed no significant effect. On scanning electron micrographs of de-endothelialized aorta, aggregating platelets adhered to the subendothelium, with loss of their discoid shape, to form irregular spheres with pseudo- pod extensions. Triflavin (2 μmol/L) markedly reduced the adhesion of platelets to the subendothelium in the same aorta. Furthermore, RGD-containing peptides (including triflavin, trigramin, and small RGD-containing peptides) inhibited the adhesion of 10 μg/mL collagen-activated platelets to extracellular matrices (ie, fibronectin, vitronectin, and von Willebrand factor). It is concluded that the marked ability of triflavin to inhibit aggregating platelet-induced vasoconstriction in de-endothelialized aorta compared with other RGD-containing peptides (including trigramin), may be due at least partly to triflavin's efficiently preventing the activation of platelets subsequent to inhibition of serotonin release and thromboxane A2 formation. However, the different abilities of triflavin compared with other RGD- containing peptides was not related to the ability to inhibit adhesion of platelets to extracellular matrices. Therefore, from the results of this study, it appears that triflavin map be a useful therapeutic agent for the treatment of thromboembolism and its associated angiospasm.

Original languageEnglish
Pages (from-to)3461-3468
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume17
Issue number12
Publication statusPublished - 1997

Fingerprint

Vasoconstriction
Aorta
Blood Platelets
glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine
glycyl-arginyl-glycyl-aspartyl-serine
Thromboxane A2
Extracellular Matrix
Serotonin
Trimeresurus
triflavin
Disintegrins
Vitronectin
arginyl-glycyl-aspartic acid
Peptides
Snake Venoms
Thromboembolism
Platelet Activation
Venoms
von Willebrand Factor
Phenylephrine

Keywords

  • De- endothelialization
  • RGD-containing peptides
  • Serotonin
  • Thromboxanes
  • Triflavin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sheu, J. R., Yen, M. H., Hung, W. C., Lee, Y. M., Su, C-H., & Huang, T. F. (1997). Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(12), 3461-3468.

Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta. / Sheu, J. R.; Yen, M. H.; Hung, W. C.; Lee, Y. M.; Su, Ching-Hua; Huang, T. F.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 12, 1997, p. 3461-3468.

Research output: Contribution to journalArticle

Sheu, JR, Yen, MH, Hung, WC, Lee, YM, Su, C-H & Huang, TF 1997, 'Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 12, pp. 3461-3468.
Sheu, J. R. ; Yen, M. H. ; Hung, W. C. ; Lee, Y. M. ; Su, Ching-Hua ; Huang, T. F. / Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1997 ; Vol. 17, No. 12. pp. 3461-3468.
@article{376ac2bbece944098f2ae9b010d56725,
title = "Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta",
abstract = "Triflavin, a 7.5-kD cysteine-rich polypeptide purified from Trimeresurus favoviridis snake venom, belongs to a family of Arg-Gly-Asp-(RGD)-containing peptides, termed disintegrins. In this study, aggregating human platelets dose-dependently induced vasoconstriction in de-endothelialized isolated rat thoracic aortas. At 5 x 107 cells per milliliter, platelets induced a peak tension averaging 65±7.2{\%} of the tension induced by phenylephrine (10 μmol/L). The relative effectiveness of RGD-containing peptides (including venom peptides triflavin and trigramin, small RGD synthetic peptides Gly- Arg-Gly-Asp-Ser [GRGDS], Gly-Arg-Gly-Asp-Phe [GRGDF], and Gly-Arg-Gly-Asp- Ser-Pro-Lys [GRGDSPK]) was examined by testing the inhibitory effect on aggregating platelet-induced vasoconstriction in de-endothelialized aorta. Triflavin (1 mmol/L) significantly inhibited the platelet-induced vasoconstriction, whereas neither trigramin (10 μmol/L) nor small RGD peptides (2 mmol/L) (ie, GRGDS, GRGDF, and GRGDSPK) showed any significant effect. The release of serotonin and the formation of thromboxane A2 from aggregating platelets were both significantly inhibited by triflavin (2 μmol/L), whereas trigramin and small RGD-containing peptides showed no significant effect. On scanning electron micrographs of de-endothelialized aorta, aggregating platelets adhered to the subendothelium, with loss of their discoid shape, to form irregular spheres with pseudo- pod extensions. Triflavin (2 μmol/L) markedly reduced the adhesion of platelets to the subendothelium in the same aorta. Furthermore, RGD-containing peptides (including triflavin, trigramin, and small RGD-containing peptides) inhibited the adhesion of 10 μg/mL collagen-activated platelets to extracellular matrices (ie, fibronectin, vitronectin, and von Willebrand factor). It is concluded that the marked ability of triflavin to inhibit aggregating platelet-induced vasoconstriction in de-endothelialized aorta compared with other RGD-containing peptides (including trigramin), may be due at least partly to triflavin's efficiently preventing the activation of platelets subsequent to inhibition of serotonin release and thromboxane A2 formation. However, the different abilities of triflavin compared with other RGD- containing peptides was not related to the ability to inhibit adhesion of platelets to extracellular matrices. Therefore, from the results of this study, it appears that triflavin map be a useful therapeutic agent for the treatment of thromboembolism and its associated angiospasm.",
keywords = "De- endothelialization, RGD-containing peptides, Serotonin, Thromboxanes, Triflavin",
author = "Sheu, {J. R.} and Yen, {M. H.} and Hung, {W. C.} and Lee, {Y. M.} and Ching-Hua Su and Huang, {T. F.}",
year = "1997",
language = "English",
volume = "17",
pages = "3461--3468",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Triflavin inhibits platelet-induced vasoconstriction in de- endothelialized aorta

AU - Sheu, J. R.

AU - Yen, M. H.

AU - Hung, W. C.

AU - Lee, Y. M.

AU - Su, Ching-Hua

AU - Huang, T. F.

PY - 1997

Y1 - 1997

N2 - Triflavin, a 7.5-kD cysteine-rich polypeptide purified from Trimeresurus favoviridis snake venom, belongs to a family of Arg-Gly-Asp-(RGD)-containing peptides, termed disintegrins. In this study, aggregating human platelets dose-dependently induced vasoconstriction in de-endothelialized isolated rat thoracic aortas. At 5 x 107 cells per milliliter, platelets induced a peak tension averaging 65±7.2% of the tension induced by phenylephrine (10 μmol/L). The relative effectiveness of RGD-containing peptides (including venom peptides triflavin and trigramin, small RGD synthetic peptides Gly- Arg-Gly-Asp-Ser [GRGDS], Gly-Arg-Gly-Asp-Phe [GRGDF], and Gly-Arg-Gly-Asp- Ser-Pro-Lys [GRGDSPK]) was examined by testing the inhibitory effect on aggregating platelet-induced vasoconstriction in de-endothelialized aorta. Triflavin (1 mmol/L) significantly inhibited the platelet-induced vasoconstriction, whereas neither trigramin (10 μmol/L) nor small RGD peptides (2 mmol/L) (ie, GRGDS, GRGDF, and GRGDSPK) showed any significant effect. The release of serotonin and the formation of thromboxane A2 from aggregating platelets were both significantly inhibited by triflavin (2 μmol/L), whereas trigramin and small RGD-containing peptides showed no significant effect. On scanning electron micrographs of de-endothelialized aorta, aggregating platelets adhered to the subendothelium, with loss of their discoid shape, to form irregular spheres with pseudo- pod extensions. Triflavin (2 μmol/L) markedly reduced the adhesion of platelets to the subendothelium in the same aorta. Furthermore, RGD-containing peptides (including triflavin, trigramin, and small RGD-containing peptides) inhibited the adhesion of 10 μg/mL collagen-activated platelets to extracellular matrices (ie, fibronectin, vitronectin, and von Willebrand factor). It is concluded that the marked ability of triflavin to inhibit aggregating platelet-induced vasoconstriction in de-endothelialized aorta compared with other RGD-containing peptides (including trigramin), may be due at least partly to triflavin's efficiently preventing the activation of platelets subsequent to inhibition of serotonin release and thromboxane A2 formation. However, the different abilities of triflavin compared with other RGD- containing peptides was not related to the ability to inhibit adhesion of platelets to extracellular matrices. Therefore, from the results of this study, it appears that triflavin map be a useful therapeutic agent for the treatment of thromboembolism and its associated angiospasm.

AB - Triflavin, a 7.5-kD cysteine-rich polypeptide purified from Trimeresurus favoviridis snake venom, belongs to a family of Arg-Gly-Asp-(RGD)-containing peptides, termed disintegrins. In this study, aggregating human platelets dose-dependently induced vasoconstriction in de-endothelialized isolated rat thoracic aortas. At 5 x 107 cells per milliliter, platelets induced a peak tension averaging 65±7.2% of the tension induced by phenylephrine (10 μmol/L). The relative effectiveness of RGD-containing peptides (including venom peptides triflavin and trigramin, small RGD synthetic peptides Gly- Arg-Gly-Asp-Ser [GRGDS], Gly-Arg-Gly-Asp-Phe [GRGDF], and Gly-Arg-Gly-Asp- Ser-Pro-Lys [GRGDSPK]) was examined by testing the inhibitory effect on aggregating platelet-induced vasoconstriction in de-endothelialized aorta. Triflavin (1 mmol/L) significantly inhibited the platelet-induced vasoconstriction, whereas neither trigramin (10 μmol/L) nor small RGD peptides (2 mmol/L) (ie, GRGDS, GRGDF, and GRGDSPK) showed any significant effect. The release of serotonin and the formation of thromboxane A2 from aggregating platelets were both significantly inhibited by triflavin (2 μmol/L), whereas trigramin and small RGD-containing peptides showed no significant effect. On scanning electron micrographs of de-endothelialized aorta, aggregating platelets adhered to the subendothelium, with loss of their discoid shape, to form irregular spheres with pseudo- pod extensions. Triflavin (2 μmol/L) markedly reduced the adhesion of platelets to the subendothelium in the same aorta. Furthermore, RGD-containing peptides (including triflavin, trigramin, and small RGD-containing peptides) inhibited the adhesion of 10 μg/mL collagen-activated platelets to extracellular matrices (ie, fibronectin, vitronectin, and von Willebrand factor). It is concluded that the marked ability of triflavin to inhibit aggregating platelet-induced vasoconstriction in de-endothelialized aorta compared with other RGD-containing peptides (including trigramin), may be due at least partly to triflavin's efficiently preventing the activation of platelets subsequent to inhibition of serotonin release and thromboxane A2 formation. However, the different abilities of triflavin compared with other RGD- containing peptides was not related to the ability to inhibit adhesion of platelets to extracellular matrices. Therefore, from the results of this study, it appears that triflavin map be a useful therapeutic agent for the treatment of thromboembolism and its associated angiospasm.

KW - De- endothelialization

KW - RGD-containing peptides

KW - Serotonin

KW - Thromboxanes

KW - Triflavin

UR - http://www.scopus.com/inward/record.url?scp=0031472071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031472071&partnerID=8YFLogxK

M3 - Article

C2 - 9437193

AN - SCOPUS:0031472071

VL - 17

SP - 3461

EP - 3468

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 12

ER -